NCT05272514

Brief Summary

The purpose of this study is to better understand how hypoxia (low oxygen) affects resting and exertional right ventricular function in healthy individuals.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Apr 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 8, 2022

Completed
29 days until next milestone

First Posted

Study publicly available on registry

March 9, 2022

Completed
1 month until next milestone

Study Start

First participant enrolled

April 15, 2022

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2022

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2022

Completed
Last Updated

May 9, 2023

Status Verified

May 1, 2023

Enrollment Period

5 months

First QC Date

February 8, 2022

Last Update Submit

May 5, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Right ventricular contractility measured by conductance catheter

    End-systolic elastance (Ees) in mmHg/mL

    Up to 1 hour

  • Right ventricular lusitropy (diastolic function) measured by conductance catheter

    Minimum dp/dt in mmHg/sec

    Up to 1 hour

Secondary Outcomes (7)

  • Right ventricular stroke work measured by conductance catheter

    Up to 1 hour

  • Mean pulmonary artery pressure measured by right heart catheterization

    Up to 1 hour

  • Cardiac output derived from right heart catheterization

    Up to 1 hour

  • Workload

    Up to 1 hour

  • Maximal oxygen uptake

    Up to 1 hour

  • +2 more secondary outcomes

Study Arms (1)

Healthy individuals

10 healthy individuals will be recruited.

Other: Hypoxia

Interventions

HypoxiaOTHER

Individuals will be exposed to varying levels of hypoxia according to the protocol detailed above.

Healthy individuals

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

10 healthy men and women

You may qualify if:

  • Age 18 - 60
  • For women, premenopausal status

You may not qualify if:

  • Active cardiovascular or pulmonary disease (e.g. hypertension, coronary artery disease, cardiomyopathy, arrhythmia, valvular abnormalities, diabetes, peripheral vascular disease, tobacco use, chronic obstructive pulmonary disease, asthma, interstitial lung disease, restrictive lung disease, or pulmonary hypertension)
  • Use of cardiac- or pulmonary-related medications
  • Prior history of high altitude pulmonary edema or high altitude cerebral edema
  • Body mass index \< 18.5 or \> 30
  • Anemia
  • Iron deficiency
  • Iron supplementation (oral or intravenous) in the preceding 60 days
  • Systemic anticoagulation or aspirin use that cannot be temporarily held for the study
  • Pregnancy
  • Non-cardiopulmonary disorders that adversely influence exercise ability (e.g. arthritis or peripheral vascular disease)
  • Dedicated athletic training (defined here as spending \>9 hours per week in vigorous physical activity \[≥6 mets\])
  • Regular high-altitude exercise (defined here as engaging in vigorous physical activity \[≥1 hour at ≥6 mets\] at ≥8,000 ft for \>2 days per week over the preceding 4 weeks)
  • Residence at ≥8,000 ft for 3 or more consecutive nights in the preceding 30 days

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Colorado Anschutz Medical Campus

Aurora, Colorado, 80045, United States

Location

Related Publications (5)

  • Smith TG, Balanos GM, Croft QP, Talbot NP, Dorrington KL, Ratcliffe PJ, Robbins PA. The increase in pulmonary arterial pressure caused by hypoxia depends on iron status. J Physiol. 2008 Dec 15;586(24):5999-6005. doi: 10.1113/jphysiol.2008.160960. Epub 2008 Oct 27.

    PMID: 18955380BACKGROUND
  • Smith TG, Talbot NP, Privat C, Rivera-Ch M, Nickol AH, Ratcliffe PJ, Dorrington KL, Leon-Velarde F, Robbins PA. Effects of iron supplementation and depletion on hypoxic pulmonary hypertension: two randomized controlled trials. JAMA. 2009 Oct 7;302(13):1444-50. doi: 10.1001/jama.2009.1404.

    PMID: 19809026BACKGROUND
  • Cornwell WK, Tran T, Cerbin L, Coe G, Muralidhar A, Hunter K, Altman N, Ambardekar AV, Tompkins C, Zipse M, Schulte M, O'Gean K, Ostertag M, Hoffman J, Pal JD, Lawley JS, Levine BD, Wolfel E, Kohrt WM, Buttrick P. New insights into resting and exertional right ventricular performance in the healthy heart through real-time pressure-volume analysis. J Physiol. 2020 Jul;598(13):2575-2587. doi: 10.1113/JP279759. Epub 2020 May 18.

    PMID: 32347547BACKGROUND
  • Cornwell WK 3rd, Baggish AL, Bhatta YKD, Brosnan MJ, Dehnert C, Guseh JS, Hammer D, Levine BD, Parati G, Wolfel EE; American Heart Association Exercise, Cardiac Rehabilitation, and Secondary Prevention Committee of the Council on Clinical Cardiology; and Council on Arteriosclerosis, Thrombosis and Vascular Biology. Clinical Implications for Exercise at Altitude Among Individuals With Cardiovascular Disease: A Scientific Statement From the American Heart Association. J Am Heart Assoc. 2021 Oct 5;10(19):e023225. doi: 10.1161/JAHA.121.023225. Epub 2021 Sep 9.

    PMID: 34496612BACKGROUND
  • Forbes LM, Bull TM, Lahm T, Lawley JS, Hunter K, Levine BD, Lovering A, Roach RC, Subudhi AW, Cornwell WK 3rd. Right Ventricular Response to Acute Hypoxia among Healthy Humans. Am J Respir Crit Care Med. 2023 Aug 1;208(3):333-336. doi: 10.1164/rccm.202303-0599LE. No abstract available.

MeSH Terms

Conditions

Ventricular Dysfunction, RightHypoxia

Condition Hierarchy (Ancestors)

Ventricular DysfunctionHeart DiseasesCardiovascular DiseasesSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 8, 2022

First Posted

March 9, 2022

Study Start

April 15, 2022

Primary Completion

August 30, 2022

Study Completion

December 15, 2022

Last Updated

May 9, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will not share

Locations